(CYTK) |
| 0 (0%) 10-10 16:19 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 71.81 |
| Resistance 1: | 61.48 |
| Pivot price: | 54.90 |
| Support 1: | 52.67 |
| Support 2: | 47.22 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -537600000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 1051.323 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -167.00 |
| Return on Assets (ttm) | -24.9 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 10 Oct 2025
Investors who lost money on Cytokinetics, Incorporated(CYTK) should contact Levi & Korsinsky about pending Class Action - CYTK - PR Newswire
Fri, 10 Oct 2025
Deadline Alert: Cytokinetics, Incorporated (CYTK) - GlobeNewswire
Thu, 09 Oct 2025
Weiss Ratings Reiterates "Sell (D-)" Rating for Cytokinetics (NASDAQ:CYTK) - MarketBeat
Thu, 09 Oct 2025
CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics - PR Newswire
Thu, 09 Oct 2025
Have Insiders Sold Cytokinetics Shares Recently? - simplywall.st
Tue, 07 Oct 2025
Cytokinetics (NASDAQ:CYTK) EVP Fady Ibraham Malik Sells 2,000 Shares - MarketBeat
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
